Literature DB >> 10504399

Advantages and disadvantages of aggregating fluxes into synthetic and degradative fluxes when modelling metabolic pathways.

P De Atauri1, R Curto, J Puigjaner, A Cornish-Bowden, M Cascante.   

Abstract

It is now widely accepted that mathematical models are needed to predict the behaviour of complex metabolic networks in the cell, in order to have a rational basis for planning metabolic engineering with biotechnological or therapeutical purposes. The great complexity of metabolic networks makes it crucial to simplify them for analysis, but without violating key principles of stoichiometry or thermodynamics. We show here, however, that models for branched complex systems are sometimes obtained that violate the stoichiometry of fluxes at branch points and as a result give unrealistic metabolite concentrations at the steady state. This problem is especially important when models are constructed with the S-system form of biochemical systems theory. However, the same violation of stoichiometry can occur in metabolic control analysis if control coefficients are assumed to be constant when trying to predict the effects of large changes. We derive the appropriate matrix equations to analyse this type of problem systematically and to assess its extent in any given model.

Mesh:

Substances:

Year:  1999        PMID: 10504399     DOI: 10.1046/j.1432-1327.1999.00760.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  Metabolic control analysis aimed at the ribose synthesis pathways of tumor cells: a new strategy for antitumor drug development.

Authors:  Joan Boren; Antonio Ramos Montoya; Pedro de Atauri; Begoña Comin-Anduix; Antonio Cortes; Josep J Centelles; Wilma M Frederiks; Cornelis J F Van Noorden; Marta Cascante
Journal:  Mol Biol Rep       Date:  2002       Impact factor: 2.316

2.  Optimization of biotechnological systems through geometric programming.

Authors:  Alberto Marin-Sanguino; Eberhard O Voit; Carlos Gonzalez-Alcon; Nestor V Torres
Journal:  Theor Biol Med Model       Date:  2007-09-26       Impact factor: 2.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.